Skip to main content

Table 3 Associations between the TyG index and the primary endpoint

From: Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention

 

Model 1

Model 2

Model 3

HR

95% CI

P-value

HR

95%CI

P-value

HR

95% CI

P-value

TyG index

1.274

1.114–1.456

< 0.001

1.201

1.047–1.377

0.009

1.191

1.038–1.367

0.013

TyG tertiles

 T1

Reference

  

Reference

  

Reference

  

 T2

1.301

1.050–1.612

0.016

1.212

0.974–1.509

0.085

1.194

0.959–1.487

0.112

 T3

1.432

1.162–1.765

< 0.001

1.338

1.078–1.659

0.008

1.319

1.063–1.637

0.012

P for trend

  

< 0.001

  

0.009

  

0.013

  1. Model 1: unadjusted
  2. Model 2: adjusted for age, sex, BMI, previous PCI, presence of PAD, presence of multivessel CAD, high-sensitivity CRP, eGFR, presence of lesion’s length ≥ 20 mm
  3. Model 3: adjusted for age, sex, BMI, previous PCI, presence of PAD, presence of multivessel CAD, high-sensitivity CRP, eGFR, presence of lesion’s length ≥ 20 mm, stent length
  4. BMI body mass index, CI confidence interval, CAD coronary artery disease, CRP C-reactive protein, eGFR estimated glomerular filtration rate, HR hazard ratio, PCI percutaneous coronary intervention, PAD peripheral artery disease, TyG triglyceride-glucose